LOKIVETMAB
UNII 3D6091GOHH

Substance Identification & Data

This profile provides standardized clinical and technical data for Lokivetmab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3D6091GOHH.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1533403-95-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

3D6091GOHH

CAS Registry Number

1533403-95-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LOKIVETMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C166670

National Cancer Institute reference terminology for clinical and research data.

INN ID

10002

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lokivetmab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LOKIVETMAB

Common Names & Synonyms

IMMUNOGLOBULIN G2, ANTI-(CANIS FAMILIARIS INTERLEUKIN 31) (CANIS FAMILIARIS-MUS MUSCULUS MONOCLONAL PF-06443537 .GAMMA.2-CHAIN), DISULFIDE WITH CANIS FAMILIARIS-MUS MUSCULUS MONOCLONAL PF-06443537 .KAPPA.-CHAIN, DIMER

LOKIVETMAB (EMA EPAR: VETERINARY)

LOKIVETMAB [INN]

LOKIVETMAB [MI]